NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Today's Medical & Research News



Life Sciences


Researchers from Wyeth, Research Department provide details of new studies and findings in the area of life sciences



November 6th, 2009




Related Topics
United States
Cambridge
Life Sciences
Arthritis
Rheumatoid Arthritis
Protein Expression
Proteomics
Proteins
Rheumatology
Cytokines
A new study, 'TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines,' is now available. In this recently published article, scientists in the United States conducted a study "To investigate the expression and function of triggering receptor expressed on myeloid cells-1 (TREM-1) in the synovium of human RA patients as well as the level of soluble TREM-1 in the plasma of RA patients. Twenty-four RA synovial samples were analysed by gene expression oligonucleotide microarrays."

"Expression levels of TREM-1 mRNA in murine CIA paws were determined by quantitative PCR (qPCR). TREM-1 protein expression was detected by immunohistochemistry in five RA synovial samples and two OA synovial samples. TREM-1-positive cells from five RA synovial tissues were analysed by FACS staining to determine the cell type. Activation of TREM-1 was tested in five RA synovial samples. Soluble TREM-1 was measured in serum from 32 RA patients. The expression of TREM-1 mRNA was found to increase 6.5-fold in RA synovial samples, whereas it was increased 132-fold in CIA paws. Increased numbers of TREM-1-positive cells were seen in RA synovium sections and these cells co-expressed CD14. Using a TREM-1-activating cross-linking antibody in RA synovial cultures, multiple pro-inflammatory cytokines were induced. The average amount of soluble TREM-1 in plasma from RA patients was found to be higher than that in plasma from healthy volunteers. These findings suggest that the presence of high levels of functionally active TREM-1 in RA synovium may contribute to the development or maintenance of RA, or both. Inhibiting TREM-1 activity may, therefore, have a therapeutic effect on RA," wrote J. Kuai and colleagues, Wyeth, Research Department.

The researchers concluded: "High levels of soluble TREM-1 in the plasma of RA patients compared with healthy volunteers may indicate disease activity."

Kuai and colleagues published their study in Rheumatology (TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology, 2009;48(11):1352-8).

For more information, contact J. Kuai, Wyeth Research, Dept. of Inflammation, 200 Cambridge Park Drive, Cambridge, MA 02140 USA..

Publisher contact information for the journal Rheumatology is: Oxford University Press, Great Clarendon St., Oxford OX2 6DP, England.

Keywords: United States, Cambridge, Life Sciences, Arthritis, Rheumatoid Arthritis, Protein Expression, Proteomics, Proteins, Rheumatology, Cytokines.

This article was prepared by NewsRx editors from staff and other reports. Copyright 2009, NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login